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Translating embryology to embryonic stem cells 
(ESCs): mesendoderm (ME) specification 
A number of diseases that represent a major cause of 
morbidity and mortality in the developed world are, at 
their root, diseases of cellular deficiency. Most of the cells 
that build our tissues and organs share a common origin 
during the early events of embryogenesis: they all derive 
from a transient structure known as the primitive streak 
(PS). The specification of the distinct PS populations is 
tightly regulated in a spatial and temporal manner, giving 
rise to both endoderm and mesoderm cells. ESCs have the 
potential to produce any of the three germ layer-derived 
cells and represent an ideal and relevant in vitro system to 
recapitulate the early embryological events. During their 
in vitro differentiation into mesoderm and endoderm, 
ESCs transition an intermediate stage called ME, which is 
equivalent to the PS (1-3). The gene regulatory networks 
(GRNs) that dictate ME specification are under the control 
of distinct combinations of transcription factors (TFs) that 
are necessary to elicit cell fate and lineage determination. 
Emerging evidence suggests that GRN activity is, in 
addition to TFs, under the control of complex regulatory 
non-coding RNA networks. A better understanding of the 
non-coding RNA networks implicated in ME specification 
is needed in order to provide important insights into the 
regulatory mechanisms operating in the early embryo and 
provide novel approaches to improve stem cell commitment 
for regenerative medicine. 
Long noncoding RNAs (lncRNAs)
Among all the classes of non-coding RNAs, lncRNAs are 
operationally defined as RNA molecules that are longer 
than 200 nucleotides in length and exhibit minimal protein 
coding potential. Currently, the best characterized lncRNAs 
are typically polymerase II (Pol II) transcribed, multi-
exonic, 5’ capped, alternatively spliced and polyadenylated. 
LncRNAs are usually expressed at a lower level than 
mRNAs but importantly are characterized by a greater 
tissue and cell specificity (4-7). Recent studies have shown 
that lncRNAs regulate various biological processes such as 
chromosome inactivation (8), imprinting (9), splicing (10) 
and transcriptional control (11). LncRNAs represent a 
very dynamic class of molecules that are emerging as key 
regulators of every aspect of GRN activity, including 
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transcriptional control, post-transcriptional processing 
and chromatin remodeling (12). Recently, lncRNAs have 
been shown to be involved in the fine-tuning of GRNs 
controlling cell-fate and lineage specification. Here, we 
review the lncRNAs that have been implicated in regulating 
ME specification in vitro and/or in vivo. 
lncRNAs in ME specification
The first lncRNA shown to be required for controlling ME 
specification, specifically into the cardiac fate, was Braveheart 
(Bvht) (13). Depletion of Bvht in mouse ESCs decreases 
their ability to activate a core GRN directing cardiovascular 
cell fate. This lncRNA acts upstream of the TF mesoderm 
posterior protein 1 (MESP1), master regulator of cardiac 
mesoderm specification. Bvht interacts with the epigenetic 
silencer polycomb repressive complex 2 (PCR2), possibly 
displacing PRC2 from the MesP1 locus to activate cardiac 
mesoderm-specific genes. Very recently, the mechanism 
of action of Bvht has been characterized in detail. The 
secondary structure of this lncRNA was determined and 
the 5’ asymmetric G-rich internal loop (AGIL) was shown 
to be essential for Bvht function (14). Indeed, mouse ESCs 
carrying a specific deletion of AGIL showed impaired 
cardiogenic differentiation. Importantly, Bvht interacts 
through AGIL with CNBP, a zing finger TF which acts 
as negative regulator of the cardiac gene program. Our 
group has characterized a lncRNA associated with the same 
locus controlling Bvht in mouse. This novel lncRNA called 
CARMEN, (Car)diac (M)esoderm (E)nhancer-associated 
(N)oncoding RNA, was identified as one of the most up-
regulated lncRNAs during the cardiac differentiation of 
human cardiac progenitor cells (CPCs) isolated from the 
fetal human heart (15). As opposed to Bvht, Carmen is 
conserved in human and is associated to an active super-
enhancer in both the fetal and human heart. Carmen loss 
of function (LoF) by shRNAi in mouse P19CL6s resulted 
in a decreased ability of the cells to differentiate into the 
cardiac lineage. Interestingly, Carmen depletion resulted in 
the down-regulation of Eomesodermin (Eomes), a crucial TF 
known to dictate mesoderm and definitive endoderm (DE) 
specification. Thus, Carmen acts upstream of Eomes in the 
GRNs driving early ME specification. 
LncRNA that are transcribed on the opposite strand to 
their neighboring protein coding gene are named divergent 
lncRNAs and comprise ~20% of the total lncRNAs in 
the mammalian genome. The first example of a divergent 
lncRNA implicated in early development was Fendrr, 
transcribed divergently from the TF forkhead box F1 
(FOXF) (16). Fendrr is specifically expressed in the lateral 
plate mesoderm of the developing embryo and interacts 
with both activating (TrxG/MLL) and repressive (PCR2) 
chromatin modifying complexes to modulate expression of 
specific TFs implicated in the development of the heart. 
Fendrr KO resulted in embryonic lethality at embryonic 
day 13.75 with abdominal wall defects and pooling of 
blood in the right atrium. An important feature of Fendrr 
is its long-term effect. Epigenetic signatures, like the ones 
established via Fendrr activity, persist through several 
stages of differentiation. Fendrr is therefore a modulator of 
the epigenetic landscape during early development. The 
crosstalk between Fendrr and Foxf1 represents an example 
of an intriguing transcriptional and functional coupling of 
a divergent lncRNA with its adjacent PCG, both of which 
are essential for development of the same embryonic tissue. 
Another example of a divergent lncRNA implicated in early 
ME specification is Evx1as, transcribed on the opposite 
strand of its nearby gene Even-Skipped Homeobox 1 
(Evx1) (17). EVX1 is an important homeodomain TF 
that promotes ME specification during mouse ESC 
differentiation and its expression is highly correlated with 
its divergent lncRNA Evx1as. Both Evx1as genomic deletion 
and post-transcriptional knockdown significantly repressed 
Evx1 expression. To evaluate whether Evx1as induced Evx1 
transcription via a cis-regulatory mechanism, the authors 
artificially activated Evx1as expression using a CRISPR-
ON system. Consistent with a cis-regulatory mechanism, 
activation of Evx1as induced Evx1 expression. Finally, 
using an elegant dCas9-mediated approach to tether the 
Evx1as RNA to the promoter of Evx1as/Evx1, the authors 
demonstrated a direct role for Evx1as RNA in controlling 
Evx1 transcription through cis regulation. Very interestingly, 
the depletion of Evx1 had a lesser impact on ME 
specification than the depletion of its divergent lncRNA, 
suggesting the possibility that Evx1as acts also in trans 
independently of Evx1. DIGIT represents an alternative 
interesting antisense lncRNA, divergent to Goosecoid (GSC), 
an important regulator of ME specification. Knock-down of 
DIGIT in human ESCs impacted upon DE differentiation 
and expression of important developmental protein coding 
genes including SRY-Box 17 (SOX17) and Forkhead Box A2 
(FOXA2). DIGIT has an ortholog in mouse expressed in 
early development at E6.5, a stage corresponding to the 
formation of the anterior PS. Importantly, Digit expression 
peaks at E.7.5, when the DE is formed. Depletion of DIGIT 
via post-transcriptional approaches (shRNAs and LNAs) 
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and the insertion of a poly(A) termination sequences in 
human ESCs demonstrated that DIGIT RNA rather than 
the act of transcription at the DIGIT locus is essential for 
GSC expression. Importantly, ectopic re-expression of the 
DIGIT transcript in DIGIT-deficient cells induced GSC 
expression, as well as expression of other ME markers such 
as FOXA2 and SOX17. This suggests that DIGIT regulates 
GSC expression via a trans-regulatory mechanism as it does 
not need to be transcribed in close proximity to GSC to 
elicit its regulatory role. 
Another lncRNA implicated in early development is 
Alien. Alien starts to be expressed at the PS stage, showing 
maximal expression in the lateral plate mesoderm of 
E8.5 mouse embryos (18). This lncRNA is proximal to 
Foxa2 and is conserved in human. Alien expression correlates 
with crucial ME genes such as Brachyury (T) and Mix Paired-
Like Homeobox (Mixl1). LoF of Alien is associated with 
severe defects in multiple anatomic structures, revealing 
its importance during ME specification. In another study, 
the same lncRNA (on this occasion named DEANR1) was 
shown to be an important regulator of DE specification. 
Depletion of DEANR1 in human ESCs affects endoderm 
differentiation but is not required for maintaining the 
stemness features of ESCs. Interestingly, DEANR1 regulates 
FOXA2 expression by facilitating SMAD2/3 binding at the 
FOXA2 promoter.
Deng and colleagues identified and characterized 
HoxBlinc, a lncRNA transcribed in the Homeobox B (hoxb) 
gene locus upstream of the hoxb4 gene (19). HoxBlinc 
depletion during mouse ESCs differentiation affects hoxb 
genes and other crucial regulators of ME specification such 
as Eomes and Mesp1. Using RNA immune precipitation (RIP) 
and chromatin isolation by RNA purification (ChIRP), the 
authors demonstrated that the HoxBlinc transcript binds to 
the promoters of the hoxb1-hoxb6 genes and recruits Set1/
MLL1 complexes, driving H3K4me3 to the promoters 
of the hoxb genes. Importantly, HoxBlinc RNA regulates 
the chromatin looping of the hoxb gene cluster, locking 
the hoxb locus in a permissive conformation for being 
actively transcribed and drive ME specification into the 
hematopoietic lineages. 
Conclusions
The assumption that the GRNs controlling cell fate 
specification were primarily protein-based regulatory 
systems has been somewhat premature. We are now 
beginning to appreciate and decipher the complex roles 
of lncRNAs in contributing to the regulation of GRNs 
dictating ME specification. In the near future, we envisage 
that the manipulation of this new class of regulatory 
molecules may facilitate the development of more efficient 
cell differentiation protocols for regenerative medicine. 
Finally, understanding the roles of lncRNAs in development 
and cell differentiation is crucial to develop therapeutic 
approaches to treat human diseases for which lncRNA 
dysregulation is reported.
Acknowledgements
Financial support was granted by the Research Commission, 
Faculty of Biology and Medicine, University of Lausanne, 
Switzerland (T Pedrazzini. Additional funding was provided 
by the Pierre Mercier Foundation, Lausanne, Switzerland (S 
Ounzain). 
Footnote
Conflicts of Interest: The authors have no conflicts of interest 
to declare.
References
1. Yu P, Pan G, Yu J, et al. FGF2 sustains NANOG and 
switches the outcome of BMP4-induced human embryonic 
stem cell differentiation. Cell Stem Cell 2011;8:326-34.
2. Gouon-Evans V, Boussemart L, Gadue P, et al. BMP-4 
is required for hepatic specification of mouse embryonic 
stem cell-derived definitive endoderm. Nat Biotechnol 
2006;24:1402-11.
3. Kunisada Y, Tsubooka-Yamazoe N, Shoji M, et al. Small 
molecules induce efficient differentiation into insulin-
producing cells from human induced pluripotent stem 
cells. Stem Cell Res 2012;8:274-84.
4. Cabili MN, Trapnell C, Goff L, et al. Integrative 
annotation of human large intergenic noncoding RNAs 
reveals global properties and specific subclasses. Genes 
Dev 2011;25:1915-27.
5. Derrien T, Johnson R, Bussotti G, et al. The GENCODE 
v7 catalog of human long noncoding RNAs: analysis of 
their gene structure, evolution, and expression. Genome 
Res 2012;22:1775-89.
6. Morán I, Akerman I, van de Bunt M, et al. Human beta 
cell transcriptome analysis uncovers lncRNAs that are 
tissue-specific, dynamically regulated, and abnormally 
expressed in type 2 diabetes. Cell Metab 2012;16:435-48.
S8 Alexanian et al. The roles of lncRNAs during mesendoderm specification
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2017;9(Suppl 1):S5-S8jtd.amegroups.com
7. Ramos AD, Diaz A, Nellore A, et al. Integration of 
genome-wide approaches identifies lncRNAs of adult 
neural stem cells and their progeny in vivo. Cell Stem Cell 
2013;12:616-28.
8. Zhao J, Sun BK, Erwin JA, et al. Polycomb proteins 
targeted by a short repeat RNA to the mouse X 
chromosome. Science 2008;322:750-6.
9. Latos PA, Pauler FM, Koerner MV, et al. Airn transcriptional 
overlap, but not its lncRNA products, induces imprinted 
Igf2r silencing. Science 2012;338:1469-72.
10. Tripathi V, Ellis JD, Shen Z, et al. The nuclear-retained 
noncoding RNA MALAT1 regulates alternative splicing 
by modulating SR splicing factor phosphorylation. Mol 
cell 2010;39:925-38.
11. Tsai MC, Manor O, Wan Y, et al. Long noncoding RNA 
as modular scaffold of histone modification complexes. 
Science 2010;329:689-93.
12. Ounzain S, Crippa S, Pedrazzini T. Small and long non-
coding RNAs in cardiac homeostasis and regeneration. 
Biochim Biophys Acta 2013;1833:923-33.
13. Klattenhoff CA, Scheuermann JC, Surface LE, et 
al. Braveheart, a long noncoding RNA required for 
cardiovascular lineage commitment. Cell 2013;152:570-83.
14. Xue Z, Hennelly S, Doyle B, et al. A G-Rich Motif in 
the lncRNA Braveheart Interacts with a Zinc-Finger 
Transcription Factor to Specify the Cardiovascular 
Lineage. Mol Cell 2016;64:37-50.
15. Ounzain S, Micheletti R, Arnan C, et al. CARMEN, a 
human super enhancer-associated long noncoding RNA 
controlling cardiac specification, differentiation and 
homeostasis. J Mol Cell Cardiol 2015;89:98-112.
16. Grote P, Wittler L, Hendrix D, et al. The tissue-specific 
lncRNA Fendrr is an essential regulator of heart and body 
wall development in the mouse. Dev Cell 2013;24:206-14.
17. Luo S, Lu JY, Liu L, et al. Divergent lncRNAs Regulate 
Gene Expression and Lineage Differentiation in 
Pluripotent Cells. Cell Stem Cell 2016;18:637-52.
18. Kurian L, Aguirre A, Sancho-Martinez I, et al. 
Identification of novel long noncoding RNAs underlying 
vertebrate cardiovascular development. Circulation 
2015;131:1278-90.
19. Deng C, Li Y, Zhou L, et al. HoxBlinc RNA Recruits 
Set1/MLL Complexes to Activate Hox Gene Expression 
Patterns and Mesoderm Lineage Development. Cell Rep 
2016;14:103-14.
Cite this article as: Alexanian M, Pedrazzini T, Ounzain 
S. New Lncs to mesendoderm specification. J Thorac Dis 
2017;9(Suppl 1):S5-S8. doi: 10.21037/jtd.2017.03.70
